Establishment Labs Holdings Inc. (ESTA) Dividend History

Company News

• [Latest] Global Cosmetic Surgery Market Size/Share Worth USD 207.6 Billion by 2033 at a 11.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

  The global cosmetic surgery market is expected to grow from $67.2 billion in 2023 to $207.6 billion by 2033, at a CAGR of 11.7%. The market is driven by the growing acceptability and desire for less invasive treatments, with surgical procedures and the female segment holding the highest market share.

  GlobeNewswire Inc.

  Featured Companies: INMD VERO ZBH
• Establishment Labs CEO sells over $300k in company stock By Investing.com - Investing.com Australia

  Establishment Labs CEO Juan Jose Chacon Quiros sold over $300,000 worth of company stock under a pre-arranged trading plan. The company has seen recent developments, including an expected FDA clearance for its Motiva implants and revenue growth, but also faces challenges with profitability.

  Investing.com
• Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?

  Establishment Labs (ESTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

  Zacks Investment Research

  Featured Companies: SHC
• The Analyst Landscape: 5 Takes On Establishment Labs Hldgs

  5 analysts have expressed a variety of opinions on Establishment Labs Hldgs (NASDAQ:ESTA) over the past quarter, offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2 1 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 2 0 0 0 0 3M Ago 0 2 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $59.6, a high estimate of $65.00, and a low estimate of $53.00. This current average reflects an increase of 16.86% from the previous average price target of $51.00. Deciphering Analyst Ratings: An In-Depth Analysis A comprehensive examination of how financial experts perceive Establishment Labs Hldgs is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Joanne Wuensch Citigroup Maintains Neutral $60.00 $60.00 Joanne Wuensch Citigroup Raises Buy $60.00 $49.00 Anthony Petrone Mizuho Raises Buy $65.00 $50.00 Joshua Jennings TD Cowen Raises Outperform $60.00 $50.00 Allen Gong JP Morgan Raises Overweight $53.00 $46.00 Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Establishment Labs Hldgs. This information ...Full story available on Benzinga.com

  Benzinga
• Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates

  Establishment Labs (ESTA) delivered earnings and revenue surprises of 10.77% and 4.74%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research